Geriatrics
Latest News
ADHD a new risk factor for Alzheimer’s?
“Undiscovered genetic variants that contribute to either traits or family-wide environmental risk factors, such as socioeconomic status, that may...
From the Journals
Number of global deaths by suicide increased over 30 years
Around the world, approximately 800,000 individuals die by suicide each year, while many others attempt suicide, wrote Dr. Paul Siu Fai Yip and...
From the Journals
Low depression scores may miss seniors with suicidal intent
Only half of older adults (52%) in the study met criteria for major depression, determined on the basis of the Mini International Neuropsychiatric...
Conference Coverage
Managing sleep in the elderly
Polypharmacy, behavioral issues can pose unique challenges to treating sleep problems in older adults.
Conference Coverage
Wisdom may counter loneliness, burnout in older adults
Psychosocial interventions can improve elements of wisdom in people with mental illness and in the general population, said Dr. Tanya T. Nguyen....
Conference Coverage
‘Staggering’ increase in global dementia cases predicted by 2050
Estimates of expected increases can and should inform policy and planning efforts, researchers say.
Latest News
Zero benefit of aducanumab for Alzheimer’s disease, expert panel rules
“If I had to guess, I think the data is stronger for net harm than it is for that benefit.”
Latest News
Contentious Alzheimer’s drug likely to get national coverage plan, CMS says
It will accept public comments about how Medicare should cover aducanumab through Aug. 11.
News
Chronic stress and genetics can raise the risk of Alzheimer’s disease
Long-term stress and genetic factors may act through the hypothalamic-pituitary-adrenal axis to contribute to the development of Alzheimer’s...
From the Journals
Hearing loss tied to decline in physical functioning
It's associated with slower gait and, in particular, worse balance, data suggest.
FDA/CDC
FDA fast-tracks lecanemab for Alzheimer’s disease
The drug is a humanized monoclonal antibody that selectively binds to large, soluble aggregated Abeta protofibrils.